Recent changes in the epidemiology of esophageal cancer

Surgical Oncology

Volumn 10, Issue 3, 2001, Pages 81-90

  Pera, Manuel ^a   Pera, Miguel ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; NICOTINIC ACID; SATURATED FATTY ACID; XANTHOPHYLL; ZEAXANTHIN;

ADENOCARCINOMA; AGE; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; BARRETT ESOPHAGUS; CANCER INCIDENCE; CANCER RISK; DIET; DRUG EXPOSURE; ESOPHAGUS CARCINOMA; GASTROESOPHAGEAL REFLUX; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; LOWER ESOPHAGUS SPHINCTER; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK FACTOR; SEX RATIO; SMOKING; SQUAMOUS CELL CARCINOMA; TOBACCO;

EID: 0035670979     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(01)00025-1     Document Type: Short Survey

References (91)

1. Estimates of the worldwide incidence of eighteen major cancers in 1985
2. Esophageal cancer trends and risk factors
3. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
4. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
5. Excess incidence of squamous cell esophageal cancer among US black men: Role of social class and other risk factors
6. Role of macronutrients, vitamins and minerals in the aetiology of squamous-cell carcinoma of the oesophagus
7. Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women
8. Le cancer de l'oesophage en ille-et-vilaine en fonction des niveaux de consommation d'alcohol et de tabac. Des risques qui se multiplient
9. Smoking, type of alcoholic beverage and squamous-cell oesophageal cancer in northern Italy
10. Alcohol, tobacco and oesophageal cancer: Effects of the duration of consumption, mean intake and current and former consumption
11. Population based cohort study of the association between alcohol intake and cancer of the upper digestive tract
12. Oesophageal cancer and alcohol consumption: Importance of type of beverage
13. Oesophageal cancer in France: Potential importance of hot alcoholic drinks
14. Smoking and drinking cessation and the risk of oesophageal cancer
15. Dietary factors and the risk of squamous cell esophageal cancer among black and white men in the United States
16. Diet and squamous-cell cancer of the oesophagus: A French multicenter case-control study
17. Risk factors for oesophageal cancer in northeast China
18. Food groups and risk of squamous cell esophageal cancer in northern Italy
19. Vitamin A and other dietary factors in the etiology of esophageal cancer
20. Serum micronutrients and upper aerodigestive tract cancer
21. Vitamin supplement use and risk for oral and esophageal cancer
22. Antioxidants and cancers of the esophagus and gastric cardia
23. Nutritional aspects in oesophageal carcinogenesis
24. Influence of mate drinking, hot beverages, and diet on esophageal cancer risk in South America
25. Meat intake and risk of squamous cell esophageal cancer: A case-control study in Uruguay
26. Fiber intake and the risk of oral, pharyngeal and esophageal cancer
27. Inverse association between intake of cereal fiber and risk of gastric cardia cancer
28. Adenocarcinoma of the esophagus
29. Cancer of the esophagus
30. Primary adenocarcinoma of the esophagus
31. Adenocarcinoma of the esophagus and of the oesophagogastric junction
32. Transhiatal esophageactomy for carcinoma of the esophagus and cardia
33. Comparison of three techniques of esophagectomy within a residency training program
34. A15-year review of esophageactomy for carcinoma of the esophagus and cardia
35. Esophageal carcinoma: Depth of tumor invasion is predictive of regional lymph node status
36. Comparison of prevalence and resection rates in patients with esophageal squamous cell carcinoma and adenocarcinoma
37. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden
38. Continuing climb in rates of esophageal adenocarcinoma: An update
39. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction
40. Incidence of cancer of the esophagus in the US by histologic type
41. National cancer data base report on esophageal carcinoma
42. The changing incidence of oesophageal cancer
43. Incidence of cancer of the esophagus, cardia and stomach in Denmark
44. The rising trend in esophageal adenocarcinoma and gastric cardia
45. Adenocarcinoma of the esophagus in Switzerland
46. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries
47. The time trend and age-period-cohort effects on incidence of adenocarcinoma of the stomach in Connecticut from 1955-1989
48. Increasing incidence of adenocarcinoma of the gastric cardia and adjacents sites
49. Prevalence of Barrett's esophagus and intestinal metaplasia at the esophagogastric junction
50. Clinical epidemiologic and morphologic comparison between adenocarcinomas arising in Barrett's esophageal mucosa and gastric cardia
51. Adenocarcinoma of the lower esophagus. A disease primarily of white men with Barrett's esophagus
52. Comparative features of esophageal and gastric adenocarcinomas: Recent changes in type and frequency
53. The relation of gastroesophageal reflux disease and its treatment to adenocarcinoma of the esophagus and gastric cardia
54. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
55. Symptomatic gastro-oesophageal reflux as a risk factor for oesophageal adenocarcinoma
56. Gastroesophageal reflux disease, use of H2 receptor antagonist, and risk of esophageal cancer
57. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota
58. Epidemiology of columnar-lined esophagus and adenocarcinoma
59. Is there publication bias in the reporting of cancer risk in Barrett's esophagus?
60. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett
61. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus
62. Prevalence of columnar-lined (Barrett's) esophagus: Comparison of population-based clinical and autopsy findings
63. Epidemiologic studies and the development of Barrett's esophagus
64. The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years
65. Oesophageal cancer is an uncommon cause of death in patients with Barrett's esophagus
66. Barrett's esophagus: A new look at surveillance based on emerging estimates of cancer risk
67. Barrett's esophagus: An overrated cancer risk factor
68. Racial differences in the histology, location, and risk factors of esophageal cancer
69. Adenocarcinoma of the esophagus and Barrett's esophagus: A population-based study
70. Outcome of surgical treatment of adenocarcinoma in Barrett's esophagus
71. Barrett's esophagus: Epidemiological and clinical results of a multicentric survey
72. The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined esophagus
73. The consumption of tobacco, alcohol and the risk of adenocarcinoma in Barrett's esophagus
74. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett's) esophagus
75. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia
76. Cigarette smoking and esophageal and gastric cardia adenocarcinoma
77. Obesity as a risk factor for certain types of cancer
78. Increase in weight in all birth cohorts in a general population: The Tromso study, 1974-1994
79. Body mass index and risk of adenocarcinoma of the esophagus and gastric cardia
80. Adenocarcinoma of the esophagus: Role of obesity and diet
81. Utility of endoscopic screening for upper gastrointestinal adenocarcinoma
82. Adenocarcinomas of the esophagus and gastric cardia: The role of diet
83. A case-control study of oesophageal adenocarcinoma in women: A preventable disease
84. Mechanisms of cancer inhibition by anti-oxidant nutrients
85. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma
86. The burning issue of chronic gastroesophageal reflux
87. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer
88. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection
89. An inverse relation between CagA strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma
90. Virulent Helicobacter pylori (HP) in patients with gastric and oesophageal adenocarcinoma
91. Helicobacter pylori CagA-strains predominate in gastroesophageal reflux disease, Barrett's esophagus, and esophageal dysplasia/adenocarcinoma